Ke Xu

5.7k total citations · 4 hit papers
145 papers, 4.2k citations indexed

About

Ke Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ke Xu has authored 145 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 41 papers in Cancer Research and 37 papers in Oncology. Recurrent topics in Ke Xu's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (14 papers) and Cancer Cells and Metastasis (11 papers). Ke Xu is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (14 papers) and Cancer Cells and Metastasis (11 papers). Ke Xu collaborates with scholars based in China, United States and United Kingdom. Ke Xu's co-authors include Peihao Yin, Xin Liang, Lei Yu, Jiacan Su, Yanyan Qiu, Jianwen Liu, Zeting Yuan, Xiang Wu, Boning Liu and Yueping Zhan and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Ke Xu

138 papers receiving 4.2k citations

Hit Papers

Exosome-based bone-targeting drug delivery alleviates imp... 2023 2026 2024 2025 2023 2024 2024 2025 40 80 120

Peers

Ke Xu
Sang Hun Lee South Korea
Ke Xu
Citations per year, relative to Ke Xu Ke Xu (= 1×) peers Sang Hun Lee

Countries citing papers authored by Ke Xu

Since Specialization
Citations

This map shows the geographic impact of Ke Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Xu more than expected).

Fields of papers citing papers by Ke Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Xu. The network helps show where Ke Xu may publish in the future.

Co-authorship network of co-authors of Ke Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Xu. A scholar is included among the top collaborators of Ke Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Xu. Ke Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Obata, Keisuke, et al.. (2025). Mass Activity Elucidation of Cobalt‐Based Oxygen Evolution Catalysts Utilizing Depth‐Resolved Spectroscopy in the Presence of Various Cations with Chloride. Angewandte Chemie International Edition. 64(16). e202501579–e202501579. 4 indexed citations
2.
Xu, Ke, et al.. (2025). Growth and Application of AlN Single Crystal. 1 indexed citations
3.
Zhu, Mengru, et al.. (2025). Biomineralization empowers bone organoids. Biomaterials. 326. 123703–123703. 1 indexed citations
4.
Zhou, Guangyin, Qirong Zhou, Shihao Sheng, et al.. (2025). Synthetically Engineered Bacterial Extracellular Vesicles and IL-4-Encapsulated Hydrogels Sequentially Promote Osteoporotic Fracture Repair. ACS Nano. 19(16). 16064–16083. 17 indexed citations
5.
Wang, Jian, et al.. (2025). Artificial Intelligence for Organoids Multidimensional Assessment. SmartMat. 6(3). 4 indexed citations
6.
Wang, Xiuhui, Shunli Wu, Yue Sun, et al.. (2025). ROS‐Activated Nanohydrogel Scaffolds with Multi‐Factors Controlled Release for Targeted Dual‐Lineage Repair of Osteochondral Defects. Advanced Science. 12(20). e2412410–e2412410. 7 indexed citations
7.
Chen, Yutong, Mengru Zhu, Shihao Sheng, et al.. (2025). Biomimetic Extracellular Vesicles Containing Biominerals for Targeted Osteoporosis Therapy. ACS Applied Materials & Interfaces. 17(4). 5823–5840.
8.
Zhang, Hao, Qirong Zhou, Shihao Sheng, et al.. (2025). Dynamic GelMA/DNA Dual‐Network Hydrogels Promote Woven Bone Organoid Formation and Enhance Bone Regeneration. Advanced Materials. 37(24). e2501254–e2501254. 24 indexed citations breakdown →
9.
Yan, Jing, Miaomiao Wang, Dagui Chen, et al.. (2024). SiATG5-loaded cancer cell membrane-fused liposomes induced increased uptake of albumin-bound chemotherapeutics by pancreatic cancer cells. Journal of Controlled Release. 367. 620–636. 22 indexed citations
10.
Wang, Jian, Guangfeng Li, Peiran Song, et al.. (2024). Boosting cartilage repair with silk fibroin-DNA hydrogel-based cartilage organoid precursor. Bioactive Materials. 35. 429–444. 98 indexed citations breakdown →
11.
Zhou, Fengjin, Guangfeng Li, Yan Wei, et al.. (2024). Cyaonoside A-loaded composite hydrogel microspheres to treat osteoarthritis by relieving chondrocyte inflammation. Journal of Materials Chemistry B. 12(17). 4148–4161. 9 indexed citations
12.
Zhang, Qin, Weikai Chen, Guangfeng Li, et al.. (2024). A Factor‐Free Hydrogel with ROS Scavenging and Responsive Degradation for Enhanced Diabetic Bone Healing. Small. 20(24). e2306389–e2306389. 69 indexed citations breakdown →
13.
Chen, Jinbao, Jian Xu, Jiahua Yang, et al.. (2023). α‑hederin overcomes hypoxia‑mediated drug resistance in colorectal cancer by inhibiting the AKT/Bcl2 pathway. International Journal of Oncology. 62(3). 6 indexed citations
14.
Lin, Liangjie, Ke Xu, Man Xu, et al.. (2023). Changes in aspartate metabolism in the medial‐prefrontal cortex of nicotine addicts based on J‐edited magnetic resonance spectroscopy. Human Brain Mapping. 44(18). 6429–6438. 2 indexed citations
15.
Hu, Yan, et al.. (2023). Single‐cell RNA sequencing in osteoarthritis. Cell Proliferation. 56(12). e13517–e13517. 27 indexed citations
16.
Guo, Jiawei, Fuxiao Wang, Yan Hu, et al.. (2023). Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases. Cell Reports Medicine. 4(1). 100881–100881. 129 indexed citations breakdown →
17.
Zhang, Wen Cai, et al.. (2023). Organoid assessment technologies. Clinical and Translational Medicine. 13(12). 22 indexed citations
18.
Xu, Ke, Junqi Liu, Yang Liu, et al.. (2022). Compositions analysis and insecticidal activity of Aconitum polycarpum Chang ex W.T.Wang petroleum ether fractions and essential oils. Journal of Ethnopharmacology. 303. 115989–115989. 3 indexed citations
19.
Lu, Ping, Min Fang, Lei Yao, et al.. (2022). Massage of Bladder Meridian Relieved Anxiety Induced by Chronic Stress in Rats. BioMed Research International. 2022(1). 5639716–5639716. 2 indexed citations
20.
Yuan, Zeting, Yuxia Yuan, Lin Han, et al.. (2018). Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer. International Journal of Nanomedicine. Volume 13. 7533–7548. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026